The bill establishes new provisions in Florida law regarding health insurance coverage for CAR T-cell therapies, creating sections 627.64198, 627.6614, and 641.3133 in the Florida Statutes. It defines CAR T-cell therapy and outlines that individual health insurance policies, group health insurance policies, and health maintenance contracts issued or renewed on or after January 1, 2026, cannot refuse to contract with in-network health care facilities for the administration of CAR T-cell therapies. Additionally, these policies and contracts are prohibited from denying coverage for such therapies under specified circumstances.

The bill emphasizes that health insurance policies must include coverage for the administration of CAR T cells and any necessary medications or procedures related to CAR T-cell therapy, provided that the health care facility is part of the insurance policy's provider network for other services. The effective date for these provisions is set for January 1, 2026.